Dr. Kenneth Blum received his PhD in Neuropharmacology from New York Medical College and is a graduate from Columbia University and New Jersey College of Medicine. He trained at the Institute of Behavioral Genetics, Colorado University at Boulder, Colorado. He also received a doctor of humane letters from St. Martins University. He has published over 600 abstracts, peer– reviewed articles and 17 books.He has been the recipient of many grants and awards including a Life-Time Achievement in Addiction Medicine (Holistic Institute on Addiction Studies); Marquis Who Who’s Life –Time Achievement Award, and Presidential Award for Scientific Excellence (National Council of Alcohol & Drug Abuse Councilors), Scientific Achievement Award (City of Life Miami) and Best Abstract (2012) Award ASRA (Pain); Path Foundation Lifetime Achievement Award(2014) and Honorary Full Professor (Eötvös Loránd University, Institute ofPsychology, Budapest, Hungary) and American Society of Addiction MedicineMillennium Laboratory Award and Top RegistryProfessional of the Year Award He is indeed the father of Amino-Acid Therapy for Reward Deficiency Syndrome developing Pro –Dopamine Regulation to induce “dopamine Homeostasis “coupled with genetic testing for “Precision Addiction Management”(PAM)® and Precision Behavioral Management”(PBM).® He also has a vast business experience including former Chairman of a Public Company. Most recently he is the Principal Investigator of grant from the NIH selected to be funded relate to both GARS and Pro-dopamine regulation in the African-American population along with Dr. Marjorie Gondre-Lewis Howard University and the National Human Genome Center (NHGC). He has been nominated to the board of directors of the National Whole Genome Science Foundation. 2018 among many others. He coined the term “Reward Deficiency Syndrome“ in 1995 now in Microsoft Dictionary, Gates Scientific dictionary and featured in SAGE Encyclopedia of Abnormal Psychology (2017). Selected Marquis Who’s Who Scientist of the Year (medical) 2019.
He is indeed the father of Amino-Acid Therapy for Reward Deficiency Syndrome developing Pro –Dopamine Regulation to induce “dopamine Homeostasis “coupled with genetic testing for “Precision Addiction Management”(PAM)™ and Precision Behavioral Management”(PBM).™